The treatment of recurrent Clostridium difficile (C. diff.) infection is a subject of increasing interest in the scientific literature.
We have provided links to a sampling of the most important studies related to the use of Microbiota Restoration Therapy™ (MRT™) drug platform for recurrent C. diff. infection including predecessor therapies.